[Special Stock] Seoul Viosys Launches COVID-19 99.9% Sterilization Technology Air Purifier in the US

[Asia Economy Reporter Hyungsoo Park] Seoul Viosys is showing strong performance. The news that it is launching a personal air purifier (model name: VAC) applying BioRes technology, which reduces person-to-person infection from the novel coronavirus disease (COVID-19) in the air, appears to have influenced its stock price.

At 10:34 a.m. on the 26th, Seoul Viosys was trading at 14,700 KRW, up 7.3% from the previous day.

Seoul Viosys announced that it will simultaneously launch the air purifier online in Korea and the United States in early next month. BioRes is a technology that sterilizes harmful bacteria such as bacteria by irradiating ultraviolet light-emitting diodes (LEDs) or by installing LED chips in air purifiers and air conditioners.

According to experiments commissioned to a research team at Korea University, BioRes sterilizes COVID-19 by 99.9% in just 30 seconds, and the sterilization effect improves the closer and longer the exposure to BioRes light. It has already been confirmed through experiments that BioRes can sterilize harmful bacteria such as Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and pneumonia bacteria by 99.9%.

The new product VAC will be released under the Seoul Viosys brand for rapid supply until the COVID-19 situation stabilizes, and will continue to be supplied in cooperation with partner companies. In addition, sales channels will be expanded to Europe and Southeast Asian countries next month along with the follow-up new product, a personal surface sterilizer (VSM).

This content was produced with the assistance of AI translation services.